CVS files amended complaint in Zetia antitrust case
MLex Summary: CVS Pharmacy has filed an amended complaint accusing Merck, Par Pharmaceutical and Glenmark of entering into an illegal pay-for-delay agreement that kept a generic version of the cholesterol drug Zetia out...To view the full article, register now.
Already a subscriber? Click here to view full article